UniProt ID | SH3R1_HUMAN | |
---|---|---|
UniProt AC | Q7Z6J0 | |
Protein Name | E3 ubiquitin-protein ligase SH3RF1 | |
Gene Name | SH3RF1 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 888 | |
Subcellular Localization | Cytoplasm, perinuclear region. Cell projection, lamellipodium. Cytoplasm. Golgi apparatus, trans-Golgi network. Colocalizes, with AKT2, in lamellipodia (By similarity). Colocalizes, with HERP1, in trans-Golgi network.. | |
Protein Description | Acts as a scaffold protein, contributes to Rac-induced signal transduction such as JNKs (MAPK8 and MAPK9) activation and induces apoptosis. Within a signaling complex, it probably recruits protein kinases such as MAP3K10 or MAP3K11 which are in turn activated leading to the sequential activation of MAP2K4, MAP2K7 and JNKs (MAPK8 and MAPK9) (By similarity). May be involved in targeting of HIV-1 GAG and GAG-POL polyproteins to the plasma membrane.; Might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes such as UBE2D1 or UBE2N and then transfers it to substrates. In the absence of an external substrate, it can catalyze self-ubiquitination. Stimulates ubiquitination of potassium channel KCNJ1, enhancing it's dynamin-dependent and clathrin-independent endocytosis.; Plays an essential role in the targeting of HIV-1 Gag to the plasma membrane, this function is dependent on it's RING domain, and hence it's E3 ligase activity.. | |
Protein Sequence | MDESALLDLLECPVCLERLDASAKVLPCQHTFCKRCLLGIVGSRNELRCPECRTLVGSGVEELPSNILLVRLLDGIKQRPWKPGPGGGSGTNCTNALRSQSSTVANCSSKDLQSSQGGQQPRVQSWSPPVRGIPQLPCAKALYNYEGKEPGDLKFSKGDIIILRRQVDENWYHGEVNGIHGFFPTNFVQIIKPLPQPPPQCKALYDFEVKDKEADKDCLPFAKDDVLTVIRRVDENWAEGMLADKIGIFPISYVEFNSAAKQLIEWDKPPVPGVDAGECSSAAAQSSTAPKHSDTKKNTKKRHSFTSLTMANKSSQASQNRHSMEISPPVLISSSNPTAAARISELSGLSCSAPSQVHISTTGLIVTPPPSSPVTTGPSFTFPSDVPYQAALGTLNPPLPPPPLLAATVLASTPPGATAAAAAAGMGPRPMAGSTDQIAHLRPQTRPSVYVAIYPYTPRKEDELELRKGEMFLVFERCQDGWFKGTSMHTSKIGVFPGNYVAPVTRAVTNASQAKVPMSTAGQTSRGVTMVSPSTAGGPAQKLQGNGVAGSPSVVPAAVVSAAHIQTSPQAKVLLHMTGQMTVNQARNAVRTVAAHNQERPTAAVTPIQVQNAAGLSPASVGLSHHSLASPQPAPLMPGSATHTAAISISRASAPLACAAAAPLTSPSITSASLEAEPSGRIVTVLPGLPTSPDSASSACGNSSATKPDKDSKKEKKGLLKLLSGASTKRKPRVSPPASPTLEVELGSAELPLQGAVGPELPPGGGHGRAGSCPVDGDGPVTTAVAGAALAQDAFHRKASSLDSAVPIAPPPRQACSSLGPVLNESRPVVCERHRVVVSYPPQSEAELELKEGDIVFVHKKREDGWFKGTLQRNGKTGLFPGSFVENI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
54 | Phosphorylation | LRCPECRTLVGSGVE CCCCHHHHHCCCCCC | 37.14 | 20068231 | |
58 | Phosphorylation | ECRTLVGSGVEELPS HHHHHCCCCCCCCCC | 31.99 | 22210691 | |
65 | Phosphorylation | SGVEELPSNILLVRL CCCCCCCCCEEEEEC | 49.48 | 20068231 | |
108 | Phosphorylation | SSTVANCSSKDLQSS CCCCEECCHHHHHHC | 39.98 | - | |
109 | Phosphorylation | STVANCSSKDLQSSQ CCCEECCHHHHHHCC | 32.18 | - | |
114 | Phosphorylation | CSSKDLQSSQGGQQP CCHHHHHHCCCCCCC | 31.74 | 23401153 | |
125 | Phosphorylation | GQQPRVQSWSPPVRG CCCCCCCCCCCCCCC | 27.02 | 30108239 | |
127 | Phosphorylation | QPRVQSWSPPVRGIP CCCCCCCCCCCCCCC | 25.27 | 25159151 | |
143 | Phosphorylation | LPCAKALYNYEGKEP CCCCHHHHCCCCCCC | 22.13 | - | |
145 | Phosphorylation | CAKALYNYEGKEPGD CCHHHHCCCCCCCCC | 16.70 | - | |
148 | Ubiquitination | ALYNYEGKEPGDLKF HHHCCCCCCCCCCCC | 49.12 | 29967540 | |
210 | Ubiquitination | ALYDFEVKDKEADKD EEEEEEECCHHCCCC | 56.75 | 32142685 | |
304 | Phosphorylation | KNTKKRHSFTSLTMA CCCCCCCCCEEEEEC | 33.96 | 29255136 | |
306 | Phosphorylation | TKKRHSFTSLTMANK CCCCCCCEEEEECCC | 26.33 | 29255136 | |
307 | Phosphorylation | KKRHSFTSLTMANKS CCCCCCEEEEECCCC | 21.60 | 29255136 | |
309 | Phosphorylation | RHSFTSLTMANKSSQ CCCCEEEEECCCCCH | 17.63 | 20068231 | |
314 | Phosphorylation | SLTMANKSSQASQNR EEEECCCCCHHHCCC | 27.73 | 23090842 | |
315 | Phosphorylation | LTMANKSSQASQNRH EEECCCCCHHHCCCC | 31.23 | 23090842 | |
318 | Phosphorylation | ANKSSQASQNRHSME CCCCCHHHCCCCCCE | 21.98 | 28857561 | |
323 | Phosphorylation | QASQNRHSMEISPPV HHHCCCCCCEECCCE | 18.18 | 21712546 | |
327 | Phosphorylation | NRHSMEISPPVLISS CCCCCEECCCEEECC | 15.16 | 30576142 | |
333 | Phosphorylation | ISPPVLISSSNPTAA ECCCEEECCCCHHHH | 24.45 | 23090842 | |
334 | Phosphorylation | SPPVLISSSNPTAAA CCCEEECCCCHHHHH | 27.43 | 23090842 | |
335 | Phosphorylation | PPVLISSSNPTAAAR CCEEECCCCHHHHHH | 39.78 | 23090842 | |
338 | Phosphorylation | LISSSNPTAAARISE EECCCCHHHHHHHHH | 32.93 | 23090842 | |
450 | Phosphorylation | PQTRPSVYVAIYPYT CCCCCCEEEEECCCC | 6.62 | 22817900 | |
454 | Phosphorylation | PSVYVAIYPYTPRKE CCEEEEECCCCCCCH | 4.77 | 22817900 | |
456 | Phosphorylation | VYVAIYPYTPRKEDE EEEEECCCCCCCHHC | 16.65 | 22817900 | |
472 | Phosphorylation | ELRKGEMFLVFERCQ EECCCCEEEEEEECC | 4.59 | 17535800 | |
505 | O-linked_Glycosylation | GNYVAPVTRAVTNAS CCCCCCHHHHHCCHH | 16.32 | 30059200 | |
509 | Phosphorylation | APVTRAVTNASQAKV CCHHHHHCCHHHCCC | 24.88 | 30619164 | |
512 | Phosphorylation | TRAVTNASQAKVPMS HHHHCCHHHCCCCCC | 32.51 | 30619164 | |
515 (in isoform 1) | Ubiquitination | - | 38.95 | 21906983 | |
515 | Ubiquitination | VTNASQAKVPMSTAG HCCHHHCCCCCCCCC | 38.95 | 27667366 | |
519 | O-linked_Glycosylation | SQAKVPMSTAGQTSR HHCCCCCCCCCCCCC | 14.72 | 30059200 | |
519 | Phosphorylation | SQAKVPMSTAGQTSR HHCCCCCCCCCCCCC | 14.72 | 30619164 | |
520 | O-linked_Glycosylation | QAKVPMSTAGQTSRG HCCCCCCCCCCCCCC | 28.67 | 30059200 | |
520 | Phosphorylation | QAKVPMSTAGQTSRG HCCCCCCCCCCCCCC | 28.67 | 30619164 | |
524 | Phosphorylation | PMSTAGQTSRGVTMV CCCCCCCCCCCEEEE | 21.34 | 30619164 | |
525 | O-linked_Glycosylation | MSTAGQTSRGVTMVS CCCCCCCCCCEEEEC | 21.10 | 30059200 | |
525 | Phosphorylation | MSTAGQTSRGVTMVS CCCCCCCCCCEEEEC | 21.10 | 30619164 | |
529 | Phosphorylation | GQTSRGVTMVSPSTA CCCCCCEEEECCCCC | 18.06 | 22199227 | |
532 | Phosphorylation | SRGVTMVSPSTAGGP CCCEEEECCCCCCCC | 11.43 | 25159151 | |
534 | Phosphorylation | GVTMVSPSTAGGPAQ CEEEECCCCCCCCCH | 24.31 | 28985074 | |
535 | Phosphorylation | VTMVSPSTAGGPAQK EEEECCCCCCCCCHH | 32.48 | 22199227 | |
551 | Phosphorylation | QGNGVAGSPSVVPAA CCCCCCCCCCHHCCE | 12.31 | 22199227 | |
551 | O-linked_Glycosylation | QGNGVAGSPSVVPAA CCCCCCCCCCHHCCE | 12.31 | 30059200 | |
553 | Phosphorylation | NGVAGSPSVVPAAVV CCCCCCCCHHCCEEE | 37.13 | 22199227 | |
561 | Phosphorylation | VVPAAVVSAAHIQTS HHCCEEEEHHHCCCC | 17.09 | 22199227 | |
561 | O-linked_Glycosylation | VVPAAVVSAAHIQTS HHCCEEEEHHHCCCC | 17.09 | 30059200 | |
567 | Phosphorylation | VSAAHIQTSPQAKVL EEHHHCCCCCCHHHH | 41.60 | 22199227 | |
568 | Phosphorylation | SAAHIQTSPQAKVLL EHHHCCCCCCHHHHH | 9.91 | 22199227 | |
578 | Phosphorylation | AKVLLHMTGQMTVNQ HHHHHHHHCCCHHHH | 17.32 | - | |
653 | Phosphorylation | AISISRASAPLACAA EEEEECCCCCHHHHH | 29.34 | 22199227 | |
665 | Phosphorylation | CAAAAPLTSPSITSA HHHCCCCCCCCCCCC | 37.22 | 22199227 | |
666 | Phosphorylation | AAAAPLTSPSITSAS HHCCCCCCCCCCCCE | 25.08 | 25850435 | |
668 | Phosphorylation | AAPLTSPSITSASLE CCCCCCCCCCCCEEE | 37.96 | 22199227 | |
670 | Phosphorylation | PLTSPSITSASLEAE CCCCCCCCCCEEEEC | 23.68 | 22199227 | |
671 | Phosphorylation | LTSPSITSASLEAEP CCCCCCCCCEEEECC | 17.75 | 25850435 | |
673 | Phosphorylation | SPSITSASLEAEPSG CCCCCCCEEEECCCC | 26.89 | 25850435 | |
684 | Phosphorylation | EPSGRIVTVLPGLPT CCCCCEEEEECCCCC | 17.60 | - | |
691 | Phosphorylation | TVLPGLPTSPDSASS EEECCCCCCCCCHHH | 58.91 | 22199227 | |
692 | Phosphorylation | VLPGLPTSPDSASSA EECCCCCCCCCHHHH | 25.44 | 22199227 | |
695 | Phosphorylation | GLPTSPDSASSACGN CCCCCCCCHHHHCCC | 33.17 | 22199227 | |
697 | Phosphorylation | PTSPDSASSACGNSS CCCCCCHHHHCCCCC | 23.55 | 22199227 | |
698 | Phosphorylation | TSPDSASSACGNSSA CCCCCHHHHCCCCCC | 27.56 | 22199227 | |
703 | Phosphorylation | ASSACGNSSATKPDK HHHHCCCCCCCCCCC | 13.46 | 22199227 | |
704 | Phosphorylation | SSACGNSSATKPDKD HHHCCCCCCCCCCCC | 43.91 | 22199227 | |
706 | Phosphorylation | ACGNSSATKPDKDSK HCCCCCCCCCCCCCH | 45.09 | 22199227 | |
724 | Phosphorylation | KGLLKLLSGASTKRK HHHHHHHHCCCCCCC | 42.63 | 29514088 | |
727 | Phosphorylation | LKLLSGASTKRKPRV HHHHHCCCCCCCCCC | 37.68 | 29514088 | |
728 | Phosphorylation | KLLSGASTKRKPRVS HHHHCCCCCCCCCCC | 34.04 | 29514088 | |
735 | Phosphorylation | TKRKPRVSPPASPTL CCCCCCCCCCCCCCE | 26.84 | 30278072 | |
739 | Phosphorylation | PRVSPPASPTLEVEL CCCCCCCCCCEEEEE | 24.96 | 30278072 | |
741 | Phosphorylation | VSPPASPTLEVELGS CCCCCCCCEEEEECC | 32.81 | 26055452 | |
748 | Phosphorylation | TLEVELGSAELPLQG CEEEEECCCCCCCCC | 31.06 | 27732954 | |
772 | Phosphorylation | GGHGRAGSCPVDGDG CCCCCCCCCCCCCCC | 17.79 | 21945579 | |
782 | Phosphorylation | VDGDGPVTTAVAGAA CCCCCCCHHHHHHHH | 16.51 | 21945579 | |
783 | Phosphorylation | DGDGPVTTAVAGAAL CCCCCCHHHHHHHHH | 21.26 | 21945579 | |
800 | Phosphorylation | DAFHRKASSLDSAVP HHHHHHHHCCCCCCC | 34.17 | 30266825 | |
801 | Phosphorylation | AFHRKASSLDSAVPI HHHHHHHCCCCCCCC | 40.84 | 30266825 | |
804 | Phosphorylation | RKASSLDSAVPIAPP HHHHCCCCCCCCCCC | 36.14 | 30266825 | |
817 | Phosphorylation | PPPRQACSSLGPVLN CCCCHHHHHHHHHCC | 31.45 | 28555341 | |
818 | Phosphorylation | PPRQACSSLGPVLNE CCCHHHHHHHHHCCC | 36.91 | 28555341 | |
860 | Ubiquitination | GDIVFVHKKREDGWF CCEEEEEEECCCCCE | 48.50 | 27667366 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
125 | S | Phosphorylation | Kinase | AKT1 | P31749 | GPS |
125 | S | Phosphorylation | Kinase | AKT2 | P31751 | GPS |
304 | S | Phosphorylation | Kinase | AKT1 | P31749 | PSP |
304 | S | Phosphorylation | Kinase | AKT2 | P31751 | PSP |
800 | S | Phosphorylation | Kinase | AKT1 | P31749 | GPS |
800 | S | Phosphorylation | Kinase | AKT2 | P31751 | GPS |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
304 | S | Phosphorylation |
| 17535800 |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of SH3R1_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
AKT2_HUMAN | AKT2 | physical | 14504284 | |
M3K11_HUMAN | MAP3K11 | physical | 14504284 | |
PDC6I_HUMAN | PDCD6IP | physical | 19393081 | |
KCNJ1_HUMAN | KCNJ1 | physical | 19710010 | |
SEM6A_HUMAN | SEMA6A | physical | 12421765 | |
SH3R2_HUMAN | SH3RF2 | physical | 22128169 | |
SIAH1_HUMAN | SIAH1 | physical | 16230351 | |
SIAH2_HUMAN | SIAH2 | physical | 21586138 | |
UBE2N_HUMAN | UBE2N | physical | 19393081 | |
UB2D3_HUMAN | UBE2D3 | physical | 19393081 | |
UB2D1_HUMAN | UBE2D1 | physical | 19710010 | |
HERP1_HUMAN | HERPUD1 | physical | 17420289 | |
SH3R1_HUMAN | SH3RF1 | physical | 17420289 | |
UBE2N_HUMAN | UBE2N | physical | 17420289 | |
UB2D3_HUMAN | UBE2D3 | physical | 17420289 | |
FAT1_HUMAN | FAT1 | physical | 28129444 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"Regulation of the pro-apoptotic scaffolding protein POSH by Akt."; Lyons T.R., Thorburn J., Ryan P.W., Thorburn A., Anderson S.M.,Kassenbrock C.K.; J. Biol. Chem. 282:21987-21997(2007). Cited for: INTERACTION WITH AKT1 AND AKT2, PHOSPHORYLATION AT SER-304,MUTAGENESIS OF SER-304, AND MASS SPECTROMETRY. |